Aqua Bio Technology ASA – CEO and CFO
Aqua Bio Technology ASA has appointed Kristian Flaten as Chief Executive Officer, effective from 1 August 2025.
During an interim period, Kristian will also hold the position as Chief Financial Officer.
Kristian Flaten brings over 25 years of financial and business leadership, with proven track record in management, finance, corporate governance and business development from listed growth companies and international organisations.
Kristian has a background as CFO with IDEX Biometrics ASA and Quantafuel ASA, with additional experience from BW Offshore, Eksportkreditt (Eksfin) and Handelsbanken.
Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy.
The board of Aqua Bio Technology has previously announced that the company will enter a phase with new priorities and cost adjustments. The board will conclude on these topics during the second half of 2025.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
About Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABTEC) is a distribution group i skincare and non-food. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo. market of the Oslo Stock Exchange.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom